The National Institutes of Health is permanently closing one of two pharmacies that had issues with sterility processes, according to an article on The Wall Street Journal website.
The facilities received critical reports of their sterility processes a year ago from the Food and Drug Administration.
Both facilities are located in the NIH Clinical Center, which largely treats patients who are entered in clinical studies.
An FDA inspection in May 2015 found what the agency termed “significant violations of current good manufacturing practice” at the PDS, such as failing to thoroughly investigate discrepancies in drug batches.
What To Know Now About OSHA's Updated Hazcom Rule
HealthSource of Ohio and UC Health Partner for New Medical Office Building
NorthShore Health Centers Investigates Data Security Incident 
Healthcare Ransomware Attacks Reach Record High in Q3 2026
Bon Secours Mercy Health Acquires Fauquier Health